LCRF, in partnership with patients, survivors, caregivers, loved ones, industry partners and medical leaders, is funding two $300,000 two-year awards to accelerate treatment options for people with ALK positive NSCLC Read more about this collaborative effort. buff.ly/y5mA3NV
